Benelux Unquote
ICG invests in Loparex
Last investment for ICG Europe Fund V
3i reaps €35m in Refresco Gerber IPO
Dutch bottling company lists with €1.2bn market cap
Towerbrook buys Ad Van Geloven in SBO
Lion had bought the business from Egeria in 2008
Dutch government calls private equity industry into question
Parliamentary inquiry in Netherlands sets out to prevent locust behaviour
AAC Capital buys Corilus
GP takes majority stake in MBO
3i's Element picks up Trac
Deal marks ninth bolt-on since 3i invested
Goldman Sachs and TPG to fully exit Ontex
Remaining shares sold at €25.5 apiece
Summit Partners divests Multifonds for €235m
Trade sale brings Summit's nine-year holding to an end
No municipal business tax for AIFs, says Lux authority
Luxembourg tax authority states AIFs under AIFMD not considered commercial
3i's Refresco Gerber to list in Amsterdam
3i gears up for second exit from the firm
Gimv acquires United Dutch Breweries
Former owner Egeria had held the company since 2011
Bencis buys Boval
Management team take minority stake in deal
GEM Benelux sells Nspyre
GP carved out company in 2008
b-to-v backs Effect Photonics
Company plans to commercialise its technology in near future
AAC grants overallotment option in Lucas Bols IPO
AAC raised €17m through sale of extra 1 million shares
A&M hires KPMG's Lindenbergh as managing director
Lingenbergh joins following six-year stint as partner at KPMG
Newion et al. invest in Vector Fabrics
Capital injection marks the company's series-C round
HCPE invests $25m in WeTransfer
HCPE takes minority shareholding in the business
Gimv et al. sell ActoGenix for $60m
Transaction includes $30m worth of Intrexon stock
Henq invests in Housing Anywhere
Student-to-student housing platform to expand further abroad
TTF invests in Phoenix
TTF typically invests €2-3m per company
Parcom's Bakkersland sells ZAV unit
Parcom acquired an 88% stake in Bakkersland in 2008
VC-backed Bone Therapeutics raises €32m in IPO
Dual listing gives company a market cap of €104.8m
Gimv exits Viabuild
Sale of 30% stake results in a €2.3m net capital gain for GP



